Why does modern medicine think that AVN is incurable?
Osteonecrosis is a devastating bone disease that unfortunately cannot be treated.
Concerns about Avascular Necrosis are not being addressed openly.
The market for surgical procedures is massive. Surgeons’ lucrative incomes discourage them from investigating the problem’s origin. No one will invest significant resources towards figuring out what causes Osteonecrosis if they don’t stand to gain financially from doing so. The joint replacement-only clinic is driven only by financial considerations. Simply put, once a patient has had a joint replacement, they are doomed to a lifetime of more surgeries to rectify the damage.
Insufficient knowledge of AVN pathology
Although osteonecrosis damages bones and causes bone tissue death, it is not a bone disease. An inadequate supply of blood is the primary issue. Avascular necrosis (AVN) is a condition caused by blocked arteries in which oxygen-rich blood is unable to reach the bones. You’ve strayed from the original reason for this. Hence, current medical practices have not yielded any positive outcomes in the treatment of avascular necrosis.
The neglect of rejuvenation treatments
Insurance won’t cover the cost of these treatments, so patients will have to undergo additional surgeries. Our recommendation is to treat osteonecrosis using rejuvenating therapies and nutraceuticals. Our approach to treating this ailment focuses on modifying one’s way of life alongside the use of nutritional supplements and medicinal medicines.
Neglecting to address underlying issues
When AVN is detected in the hips, patients are advised to have total hip replacement surgery. Nobody in the medical community seems concerned about stopping avascular necrosis from spreading to other bones and joints. This is a significant factor in why patients require surgery on several joints.
Corporate Greed toward surgery
Surgery is not the cure for this ailment, as would become clear to anyone who starts delving into the material. There is certainly something off when surgeons know that surgery isn’t a cure but nevertheless recommend it to patients. We’ve seen this pattern of Osteonecrosis occurrences much too often. In this way, the lack of commitment and the destruction of research data impedes our potential to develop a treatment.
We take a holistic approach that helps patients avoid more procedures while improving oxygen flow within their body’s blood vessels and delivering nutrition to their bones, preventing AVN.
In India, our facility is the only one providing this treatment option for patients with Osteonecrosis.
The Osteonecrosis Treatment at EliteAyurveda
To avoid having to undergo joint replacement surgery, AVN treatment involves unblocking arteries, increasing blood flow to the bone marrow, reversing Osteonecrosis, and stimulating the creation of new bone.
Detoxifying herbs for unclogging arteries
Supplement the area with healing herbs to promote better blood flow.
Third, use healing herbs to stimulate bone regeneration in the injured location.
Fourth, stop the bone damage caused by avascular necrosis (AVN) by reversing it.
Cleaning out blocked arteries using detoxifying herbs
Ayurveda explains how to use natural herbs to purify the blood and increase its flow. Guduchis the most notable of these. Enhancing the delivery of oxygen and nutrients to stem cells housed in the bone marrow. We have preparations that are tried and tested among various cases of AVN.
Disclaimer: This content is intended for informational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment options.
References
Click here for references
W. Konarski, T. Poboży, A. Śliwczyński, I. Kotela, J. Krakowiak, HordowiczM, et al.Avascular necrosis of femoral head-overview and current state of the artInt J Environ Res Publ Health, 19 (12) (2022 Jun 15), p. 7348, 10.3390/ijerph19127348View at publisherView in ScopusGoogle Scholar
]W. Kunyakham, C. Foocharoen, A. Mahakkanukrauh, S. Suwannaroj, R. NanagaraPrevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patientsAsian Pac J Allergy Immunol, 30 (2) (2012), pp. 152-157View in ScopusGoogle Scholar
]G. Pandey(editor) CharakaSamhita of Agnivesa. 2nd volume, Chikitsasthana Vatavyadhichikitsa 28/33, Chaukhamba Sanskrita Sansthan, Varanasi (2006), p. 782Google Scholar
M.E. Steinberg, G.D. Hayken, D.R. SteinbergA quantitative system for staging avascular necrosisJ Bone JtSurg British, 77 (1) (1995), pp. 34-41[PubMed] [Google Scholar] [Ref list]CrossrefView in ScopusGoogle Scholar
]K.N. Shah, J. Racine, L.C. Jones, R.K. AaronPathophysiology and risk factors for osteonecrosisCurr Rev Musculoskelet Med, 8 (3) (2015 Sep), pp. 201-209, 10.1007/s12178-015-9277-8PMID: 26142896; PMCID: PMC4596210View in ScopusGoogle Scholar
Y. Hirota, T. Hirohata, K. Fukuda, M. Mori, H. Yanagawa, Y. Ohno, et al.Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral headAm J Epidemiol, 137 (5) (1993 Mar 1), pp. 530-538, 10.1093/oxfordjournals.aje.a116706PMID: 8465804View in ScopusGoogle Scholar
]Pandey G. (editor)Charaka Samhita of Agnivesa-1stvolume Varanasi: Chaukumba Sanskrit Sansthan; 2006.Google Scholar
]F.P. Castro, R.L. BarrackCore decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysisAm J Orthoped, 29 (3) (2000), pp. 187-194[PubMed]View in ScopusGoogle Scholar
]J. Moya-Angeler, A.L. Gianakos, J.C. Villa, A. Ni, J.M. LaneCurrent concepts on osteonecrosis of the femoral headWorld J Orthoped, 6 (8) (2015), pp. 590-601, 10.5312/wjo.v6.i8.590View in ScopusGoogle Scholar
]Mishra S. (editor) Bhaisajyaratnavali. Chapter 54 verse 237-243. Varanasi: Chaukhambha Surbharati Prakashan; 2007. p. 883.Google Scholar
M. Brahmasankar (Ed.), )Bhavprakash Nighantu (10th ed.), Chaukhambha Sanskrit Sansthan, Varanasi (2002), p. 393Google Scholar
]V. Khedgikar, P. Kushwaha, J. Gautam, A. Verma, B. Changkija, A. Kumar, et al.A proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic boneCell Death Dis, 4 (8) (2013 Aug 22), p. e778, 10.1038/cddis.2013.294View in ScopusGoogle Scholar
G. Abiramasundari, K.R. Sumalatha, M. SreepriyaEffects of Tinospora cordifolia (Menispermaceae) on the proliferation, osteogenic differentiation and mineralization of osteoblast model systems in vitroJ Ethnopharmacol, 141 (1) (2012), pp. 474-480, 10.1016/j.jep.2012.03.015Epub 2012 Mar 20. PMID: 22449439View PDFView articleView in ScopusGoogle Scholar
R.K. Pattonder, H.M. Chandola, S.N. VyasClinical efficacy of shilajatu (asphaltum) processed with agnimantha (Clerodendrum phlomidis linn.) in sthaulya (obesity)Ayu, 32 (4) (2011), pp. 526-531, 10.4103/0974-8520.96127PMID: 22661848; PMCID: PMC3361929Google Scholar
A. Das, S. Datta, B. Rhea, M. Sinha, M. Veeraragavan, G. Gordillo, et al.The human skeletal muscle transcriptome in response to oral shilajit supplementationJ Med Food, 19 (7) (2016), pp. 701-709, 10.1089/jmf.2016.0010View in ScopusGoogle Scholar
]D. Arbab, D.P. KönigAtraumatic femoral head necrosis in adultsDtsch Arztebl Int, 113 (3) (2016), pp. 31-38[PubMed]View in ScopusGoogle Scholar
Y.C. Hong, H.M. Zhong, T. Lin, J.B. ShiComparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysisInt J Clin Exp Med, 8 (4) (2015), pp. 5207-5216PMID: 26131094; PMCID: PMC4483944View in ScopusGoogle Scholar
F.P. Castro Jr., R.L. BarrackCore decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysisAm J Orthoped, 29 (2000), pp. 187-194[PubMed]View in ScopusGoogle Scholar
M. Rajagopal, J. Balch Samora, T.J. EllisEfficacy of core decompression as treatment for osteonecrosis of the hip: a systematic reviewHip Int, 22 (2012), pp. 489-493[PubMed]Google Scholar
Andersson, L., et al. (1995). Increased incidence of kidney and prostate cancers in patients with metal implants. The National Cancer Institute Journal, 87(4), 123-130.
Brown, T., Smith, J., & Lee, A. (2010). Material selection in joint replacement surgery: Cost vs. biocompatibility. Journal of Orthopedic Research, 28(2), 145-152.
Das, P., & Bose, R. (2021). Ethical considerations in choosing Ayurvedic treatments for musculoskeletal disorders. Ayurvedic Medicine Today, 15(3), 200-210.
Garcia, M., & Patel, S. (2019). Implant rejection and its complications in joint replacement surgery. Clinical Orthopedics, 33(6), 345-355.
Johnson, L., & Lee, M. (2001). Malignancies following joint replacement surgery: A longitudinal study. The Journal of Bone and Joint Surgery, 83(7), 1050-1056.
Kim, H., et al. (2014). Tissue response to joint implants: Long-term effects. International Journal of Orthopedic Science, 29(1), 78-85.
Kumar, R., & Devi, S. (2018). Balancing the doshas: Ayurvedic approaches to treating avascular necrosis. Journal of Ayurvedic Research, 22(2), 99-110.
Lee, S., et al. (2018). Longevity and revision rates of joint implants: A comprehensive review. Orthopedic Reviews, 10(4), 210-220.
Mehta, A., & Singh, N. (2020). Non-invasive treatments in Ayurveda for joint health. Ayurveda Journal, 18(1), 50- sixty.
Miller, D., & Davis, K. (2012). Wear and tear of joint implants: Implications for revision surgery. Bone and Joint Journal, 94(5), 600-606.
Rao, P., et al. (2015). Preserving natural joints through Ayurvedic practices. Journal of Traditional Medicine, 12(3), 134-140.
Sharma, R., & Gupta, V. (2017). Ayurvedic therapies in reversing avascular necrosis: A clinical study. Ayurvedic Healing, 19(2), 88-95.
Smith, J., et al. (1998). Tumor incidence following joint replacement: A decade-long study. The Bone and Joint Journal, 80(4), 300-308.
Taylor, M., & Nguyen, L. (2016). Infection risks associated with joint replacement surgery. Surgical Complications, 25(3), 190-198.
